CD36 as a marker of acute myeloid leukemia prognosis: A systematic review

CD36 is a glycoprotein associated with resistance to chemotherapy and the recurrence of acute myeloid leukemia. This systematic review aims to evaluate the impact of CD36 on the prognosis of acute myeloid leukemia, a complex heterogeneous malignant hematopoietic disease. The Embase, Scopus, Web of S...

Full description

Saved in:
Bibliographic Details
Main Authors: Marina Chaves Amantéa, Rafaela Pires da Silva, Larissa Ranini Soares, João Lorenzo de Medeiros Pereira, Ana Paula Duarte de Souza
Format: Article
Language:English
Published: Elsevier 2025-07-01
Series:Hematology, Transfusion and Cell Therapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2531137925001294
Tags: Add Tag
No Tags, Be the first to tag this record!